{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:06:03Z","timestamp":1774685163770,"version":"3.50.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1994,7,1]],"date-time":"1994-07-01T00:00:00Z","timestamp":773020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1994,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We evaluated the effect of ONO-1078, a selective leukotriene-C4, -D4, and -E4-receptor antagonist, on bronchoconstriction intensity during inhalation challenge with dipyrone (a pyrazolone derivative) in six aspirin-sensitive asthmatics. A double-blind, randomized, crossover design was used. After ingestion of 225 mg ONO-1078 or matching placebo, subjects underwent bronchial provocation with dipyrone on two occasions, separated by 4 wk. Aerosol inhalation of dipyrone was performed increasing the concentration stepwise from 0.08 to 10% (wt\/vol). FEV1 was measured every 10 min up to 30 min after inhalation of each concentration. Threshold concentrations causing a fall in FEV1 &amp;gt; or = 20% of baseline value were 0.4% in four subjects and 2% in the other two on the placebo day. After pretreatment with ONO-1078, threshold concentration was 10% in two subjects, and no fall in FEV1 was observed in the other four, even after inhalation of 10% dipyrone. Values of PD20 were 21.9 +\/- 8.2 units (mean +\/- SEM) after placebo and 311.6 +\/- 40.3 units after ONO-1078, respectively, and a statistically significant difference occurred (p &amp;lt; 0.001). Provocation of bronchoconstriction was completely inhibited in subjects whose plasma ONO-1078 levels were more than 0.5 microgram\/ml. These results support the hypothesis that sulfidopeptide leukotriene-induced bronchoconstriction is one important component in the pathophysiology of aspirin-induced asthma.<\/jats:p>","DOI":"10.1164\/ajrccm.150.1.8025759","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T17:52:10Z","timestamp":1365097930000},"page":"254-257","source":"Crossref","is-referenced-by-count":89,"title":["Inhibition of Analgesic-Induced Asthma by Leukotriene Receptor Antagonist ONO-1078"],"prefix":"10.1093","volume":"150","author":[{"given":"H","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, Saitama Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Nagata","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Saitama Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Kuramitsu","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Saitama Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Tabe","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Saitama Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kiuchi","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Saitama Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Saitama Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Saitama Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Dohi","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Saitama Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1994,7,1]]},"container-title":["American journal of respiratory and critical care medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/150\/1\/254\/67618515\/ajrccm_150_1_254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/150\/1\/254\/67618515\/ajrccm_150_1_254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:42:02Z","timestamp":1774683722000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/150\/1\/254\/8553036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7,1]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1994,7,1]]},"published-print":{"date-parts":[[1994,7,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.150.1.8025759","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1994,7]]},"published":{"date-parts":[[1994,7,1]]}}}